Home The Word Brain	My Amedeo FAQ Privacy About
	As of September 2023, Amedeo had 10,218 active subscribers with known affiliations

Stroke

Free Subscription Articles published in Atherosclerosis Retrieve available abstracts of 88 articles: HTML format

Single Articles

September 2023
1. HAMAYA R, Goto S, Hwang D, Zhang J, et al
   Machine-learning-based prediction of fractional flow reserve after percutaneous coronary intervention.
   Atherosclerosis. 2023;383:117310.
   PubMed     Abstract available
   
   
   
2. YOSHIMOTO T, Ishiyama H, Hattori Y, Nishimura K, et al
   Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke/transient ischemic attack.
   Atherosclerosis. 2023;382:117281.
   PubMed     Abstract available
   
   
   
3. DU H, Zheng J, Li X, Dong Y, et al
   The correlation between medial pattern of intracranial arterial calcification and white matter hyperintensities.
   Atherosclerosis. 2023;381:117247.
   PubMed     Abstract available
   
   
   August 2023
4. TIAN P, Liu Y, Wang J, Xing L, et al
   Correlation of neck circumference, coronary calcification severity and cardiovascular events in Chinese elderly patients with acute coronary syndromes.
   Atherosclerosis. 2023 Aug 18:117242. doi: 10.1016/j.atherosclerosis.2023.117242.
   PubMed     Abstract available
   
   
   July 2023
5. ADAY AW, Bagheri M, Vaitinadin NS, Mosley JD, et al
   Polygenic risk score in comparison with C-reactive protein for predicting incident coronary heart disease.
   Atherosclerosis. 2023;379:117194.
   PubMed     Abstract available
   
   
   
6. YANG XH, Tu QM, Li L, Guo YP, et al
   Triglyceride-lowering therapy for the prevention of cardiovascular events, stroke, and mortality in patients with diabetes: A meta-analysis of randomized controlled trials.
   Atherosclerosis. 2023 Jul 13:117187. doi: 10.1016/j.atherosclerosis.2023.117187.
   PubMed     Abstract available
   
   
   
7. VINK CEM, Woudstra J, Lee JM, Boerhout CKM, et al
   Sex differences in prevalence and outcomes of the different endotypes of chronic coronary syndrome in symptomatic patients undergoing invasive coronary angiography: Insights from the global ILIAS invasive coronary physiology registry.
   Atherosclerosis. 2023 Jul 8:117167. doi: 10.1016/j.atherosclerosis.2023.
   PubMed     Abstract available
   
   
   
8. LI Z, Lin C, Cai X, Hu S, et al
   Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials.
   Atherosclerosis. 2023;379:117181.
   PubMed     Abstract available
   
   
   
9. DALILA N, Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A, et al
   Plasma TSH and cardiovascular disease in the general population: A Mendelian randomization study of 105,224 individuals.
   Atherosclerosis. 2023;376:26-33.
   PubMed     Abstract available
   
   
   June 2023
10. MARFELLA R, Prattichizzo F, Sardu C, Paolisso P, et al
    Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque.
    Atherosclerosis. 2023 Jun 29:117180. doi: 10.1016/j.atherosclerosis.2023.
    PubMed     Abstract available
    
    
    
11. YANG XH, Zhang BL, Jin HM
    Reply to "Correspondence to: Association of remnant cholesterol with risk of cardiovascular disease events, stroke, and mortality: A systemic review and meta-analysis".
    Atherosclerosis. 2023 Jun 22:S0021-9150(23)04098.
    PubMed    
    
    
    
12. ZHANG K, Liu C, Sha X, Yao S, et al
    Development and validation of a prediction model to predict major adverse cardiovascular events in elderly patients undergoing noncardiac surgery: A retrospective cohort study.
    Atherosclerosis. 2023;376:71-79.
    PubMed     Abstract available
    
    
    
13. ATHANASOPOULOU E, Protogerou AD
    Correspondence to: "Association of remnant cholesterol with risk of cardiovascular disease events, stroke, and mortality: A systemic review and meta-analysis".
    Atherosclerosis. 2023 Jun 5:S0021-9150(23)00226.
    PubMed    
    
    
    May 2023
14. DOU Y, Chen B, Yu X, Ma D, et al
    Effectiveness of Internet-based health management in patients with dyslipidemia: A four-year longitudinal study.
    Atherosclerosis. 2023;376:34-42.
    PubMed     Abstract available
    
    
    April 2023
15. KIM SP, Ryu J, Kim SH, Yoon HJ, et al
    Low-dose aspirin in the primary prevention of cardiovascular diseases: A retrospective, propensity score matched study.
    Atherosclerosis. 2023;371:54-60.
    PubMed     Abstract available
    
    
    March 2023
16. YANG XH, Zhang BL, Cheng Y, Fu SK, et al
    Association of remnant cholesterol with risk of cardiovascular disease events, stroke, and mortality: A systemic review and meta-analysis.
    Atherosclerosis. 2023;371:21-31.
    PubMed     Abstract available
    
    
    
17. BAIK M, Nam HS, Heo JH, Lee HS, et al
    Differential association between apolipoprotein B and LDL cholesterol and cerebral atherosclerosis according to pre-stroke statin use.
    Atherosclerosis. 2023;371:14-20.
    PubMed     Abstract available
    
    
    
18. QADURA M, Syed MH, Anand S, Bosch J, et al
    The predictive value of interarm systolic blood pressure differences in patients with vascular disease: Sub-analysis of the COMPASS trial.
    Atherosclerosis. 2023;372:41-47.
    PubMed     Abstract available
    
    
    February 2023
19. FENG X, Zhang C, Huang X, Liu J, et al
    Machine learning improves mortality prediction in three-vessel disease.
    Atherosclerosis. 2023;367:1-7.
    PubMed     Abstract available
    
    
    November 2022
20. LI W, Luo J, Peng F, Liu R, et al
    Spatial metabolomics identifies lipid profiles of human carotid atherosclerosis.
    Atherosclerosis. 2022;364:20-28.
    PubMed     Abstract available
    
    
    
21. NOSSENT AY
    The epitranscriptome: RNA modifications in vascular remodelling.
    Atherosclerosis. 2022 Nov 9:S0021-9150(22)01500.
    PubMed     Abstract available
    
    
    
22. CHENG X, Ouyang F, Ma T, He L, et al
    The individual and joint associations of depression and sleep duration with cardiometabolic diseases and mortality: A prospective cohort study.
    Atherosclerosis. 2022;361:10-17.
    PubMed     Abstract available
    
    
    October 2022
23. YUAN D, Wang P, Jia S, Zhang C, et al
    Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention.
    Atherosclerosis. 2022 Oct 25. pii: S0021-9150(22)01495.
    PubMed     Abstract available
    
    
    
24. WETTERSTEN N, Mital R, Cushman M, Howard G, et al
    Growth hormone concentration and risk of all-cause and cardiovascular mortality: The REasons for Geographic And Racial Disparities in Stroke (REGARDS) study.
    Atherosclerosis. 2022;359:20-26.
    PubMed     Abstract available
    
    
    
25. SUN Y, Zhang H, Wang B, Chen C, et al
    Joint exposure to positive affect, life satisfaction, broad depression, and neuroticism and risk of cardiovascular diseases: A prospective cohort study.
    Atherosclerosis. 2022;359:44-51.
    PubMed     Abstract available
    
    
    September 2022
26. DE MARCHIS GM, Dittrich TD, Malik R, Zietz AV, et al
    Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke.
    Atherosclerosis. 2022 Sep 26. pii: S0021-9150(22)01433.
    PubMed     Abstract available
    
    
    
27. MA Y, Li S, Yang H, Zhang Y, et al
    Acid suppressants use and risk of atherosclerotic cardiovascular disease in middle-aged and older adults.
    Atherosclerosis. 2022;358:47-54.
    PubMed     Abstract available
    
    
    August 2022
28. SVENDSEN K, Olsen T, Vinknes KJ, Mundal LJ, et al
    Risk of stroke in genetically verified familial hypercholesterolemia: A prospective matched cohort study.
    Atherosclerosis. 2022;358:34-40.
    PubMed     Abstract available
    
    
    
29. SCHWEDHELM E, Tiedt S, Lezius S, Wolfer TA, et al
    Effective high-density lipoprotein cholesterol is associated with carotid intima-media thickness and vascular events after acute ischemic stroke.
    Atherosclerosis. 2022;357:9-13.
    PubMed     Abstract available
    
    
    
30. SABA L, Antignani PL, Gupta A, Cau R, et al
    International Union of Angiology (IUA) consensus paper on imaging strategies in atherosclerotic carotid artery imaging: From basic strategies to advanced approaches.
    Atherosclerosis. 2022;354:23-40.
    PubMed     Abstract available
    
    
    
31. CICERO AFG, Salvetti M
    Peripheral artery disease: A highly prevalent untreated and uncontrolled independent cardiovascular disease.
    Atherosclerosis. 2022;354:55-56.
    PubMed    
    
    
    July 2022
32. MCKAY AJ, Gunn LH, Ray KK
    Assessing the external validity of the SAFEHEART risk prediction model in patients with familial hypercholesterolaemia in an English routine care cohort.
    Atherosclerosis. 2022 Jul 21. pii: S0021-9150(22)01352.
    PubMed     Abstract available
    
    
    
33. SORTO P, Mayranpaa MI, Saksi J, Nuotio K, et al
    Glutamine synthetase in human carotid plaque macrophages associates with features of plaque vulnerability: An immunohistological study.
    Atherosclerosis. 2022;352:18-26.
    PubMed     Abstract available
    
    
    June 2022
34. KYTO V, Saraste A, Tornio A
    Early statin use and cardiovascular outcomes after myocardial infarction: A population-based case-control study.
    Atherosclerosis. 2022;354:8-14.
    PubMed     Abstract available
    
    
    
35. MARTENS LG, Luo J, Wermer MJH, Willems van Dijk K, et al
    The association between mitochondrial DNA abundance and stroke: A combination of multivariable-adjusted survival and Mendelian randomization analyses.
    Atherosclerosis. 2022;354:1-7.
    PubMed     Abstract available
    
    
    May 2022
36. FEINSTEIN MJ, Buzkova P, Olson NC, Doyle MF, et al
    Monocyte subsets, T cell activation profiles, and stroke in men and women: The Multi-Ethnic Study of Atherosclerosis and Cardiovascular Health Study.
    Atherosclerosis. 2022;351:18-25.
    PubMed     Abstract available
    
    
    
37. MATSUSHITA K, Gao Y, Sang Y, Ballew SH, et al
    Comparative mortality according to peripheral artery disease and coronary heart disease/stroke in the United States.
    Atherosclerosis. 2022 May 8. pii: S0021-9150(22)00221.
    PubMed     Abstract available
    
    
    
38. KE C, Shi M, Guo D, Zhu Z, et al
    Metabolomics on vascular events and death after acute ischemic stroke: A prospective matched nested case-control study.
    Atherosclerosis. 2022;351:1-8.
    PubMed     Abstract available
    
    
    
39. MATSUOKA S, Kaneko H, Okada A, Itoh H, et al
    Association of retinal atherosclerosis assessed using Keith-Wagener-Barker system with incident heart failure and other atherosclerotic cardiovascular disease: Analysis of 319,501 individuals from the general population.
    Atherosclerosis. 2022;348:68-74.
    PubMed     Abstract available
    
    
    
40. BOFFA MB
    Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis.
    Atherosclerosis. 2022;349:72-81.
    PubMed     Abstract available
    
    
    
41. ARSENAULT BJ, Kamstrup PR
    Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective.
    Atherosclerosis. 2022;349:7-16.
    PubMed     Abstract available
    
    
    April 2022
42. CHO IY, Yoo JE, Han K, Kim D, et al
    Frequent drinking is more predictive of ischemic stroke than binge drinking, but not of myocardial infarction.
    Atherosclerosis. 2022;350:65-72.
    PubMed     Abstract available
    
    
    
43. LUCCI C, van den Beukel TC, Bartstra JW, Zwanenburg J, et al
    Intracranial atherosclerosis in pseudoxanthoma elasticum: A case-control study.
    Atherosclerosis. 2022;350:19-24.
    PubMed     Abstract available
    
    
    March 2022
44. KHARE HA, Dossing KBV, Ringgaard L, Christensen E, et al
    In vivo detection of urokinase-type plasminogen activator receptor (uPAR) expression in arterial atherogenesis using [(64)Cu]Cu-DOTA-AE105 positron emission tomography (PET).
    Atherosclerosis. 2022 Mar 30. pii: S0021-9150(22)00159.
    PubMed     Abstract available
    
    
    
45. REN S, Hansbro PM, Srikusalanukul W, Horvat JC, et al
    Generation of cardio-protective antibodies after pneumococcal polysaccharide vaccine: Early results from a randomised controlled trial.
    Atherosclerosis. 2022;346:68-74.
    PubMed     Abstract available
    
    
    February 2022
46. PASZEK E, Pociask E, Zabczyk M, Piorkowski A, et al
    Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients.
    Atherosclerosis. 2022 Feb 11. pii: S0021-9150(22)00078.
    PubMed     Abstract available
    
    
    January 2022
47. SIUDUT J, Natorska J, Wypasek E, Wiewiorka L, et al
    Apolipoproteins and lipoprotein(a) as factors modulating fibrin clot properties in patients with severe aortic stenosis.
    Atherosclerosis. 2022;344:49-56.
    PubMed     Abstract available
    
    
    
48. YOSHIDA Y, Chen Z, Baudier RL, Krousel-Wood M, et al
    Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women.
    Atherosclerosis. 2022;344:13-19.
    PubMed     Abstract available
    
    
    
49. HE X, Dong B, Liang W, Wu Y, et al
    Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data.
    Atherosclerosis. 2022;344:1-6.
    PubMed     Abstract available
    
    
    October 2021
50. HOU HQ, Xiang XL, Pan YS, Zhang QH, et al
    Baseline or 90-day fibrinogen levels and long-term outcomes after ischemic stroke or TIA: Results from the China national stroke registry .
    Atherosclerosis. 2021;337:35-41.
    PubMed     Abstract available
    
    
    
51. LUIJTEN SPR, van der Donk SC, Compagne KCJ, Yo LSF, et al
    Intracranial carotid artery calcification subtype and collaterals in patients undergoing endovascular thrombectomy.
    Atherosclerosis. 2021;337:1-6.
    PubMed     Abstract available
    
    
    August 2021
52. SATO R, Okada K, Akiyama E, Konishi M, et al
    Impact of sarcopenic obesity on long-term clinical outcomes after ST-segment elevation myocardial infarction.
    Atherosclerosis. 2021 Aug 27. pii: S0021-9150(21)01294.
    PubMed     Abstract available
    
    
    
53. PENG R, Liu K, Li W, Yuan Y, et al
    Blood urea nitrogen, blood urea nitrogen to creatinine ratio and incident stroke: The Dongfeng-Tongji cohort.
    Atherosclerosis. 2021;333:1-8.
    PubMed     Abstract available
    
    
    July 2021
54. ZHU Z, He Y, Shi M, Guo D, et al
    Plasma osteopontin levels and adverse clinical outcomes after ischemic stroke.
    Atherosclerosis. 2021;332:33-40.
    PubMed     Abstract available
    
    
    
55. DE LUCA G, Debel N, Cercek M, Jensen LO, et al
    Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry.
    Atherosclerosis. 2021;332:48-54.
    PubMed     Abstract available
    
    
    June 2021
56. PAQUETTE M, Fantino M, Bernard S, Baass A, et al
    Paternal inheritance predicts earlier cardiovascular event onset in patients with familial hypercholesterolemia.
    Atherosclerosis. 2021;329:9-13.
    PubMed     Abstract available
    
    
    
57. VAN DAM-NOLEN DHK, van Dijk AC, Crombag GAJC, Lucci C, et al
    Lipoprotein(a) levels and atherosclerotic plaque characteristics in the carotid artery: The Plaque at RISK (PARISK) study.
    Atherosclerosis. 2021;329:22-29.
    PubMed     Abstract available
    
    
    
58. CHO Y, Jeong Y, Seo DH, Ahn SH, et al
    Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study.
    Atherosclerosis. 2021;328:92-99.
    PubMed     Abstract available
    
    
    May 2021
59. HONDA Y, Mok Y, Mathews L, Hof JRV, et al
    Psychosocial factors and subsequent risk of hospitalizations with peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Atherosclerosis. 2021 May 9. pii: S0021-9150(21)00223.
    PubMed     Abstract available
    
    
    April 2021
60. BONETTI NR, Liberale L, Akhmedov A, Pasterk L, et al
    Long-term dietary supplementation with plant-derived omega-3 fatty acid improves outcome in experimental ischemic stroke.
    Atherosclerosis. 2021;325:89-98.
    PubMed     Abstract available
    
    
    
61. METHORST R, Pasterkamp G, van der Laan SW
    Exploring the causal inference of shear stress associated DNA methylation in carotid plaque on cardiovascular risk.
    Atherosclerosis. 2021;325:30-37.
    PubMed     Abstract available
    
    
    
62. TSUNEYOSHI S, Matsukuma Y, Kawai Y, Hiyamuta H, et al
    Association between geriatric nutritional risk index and stroke risk in hemodialysis patients: 10-Years outcome of the Q-Cohort study.
    Atherosclerosis. 2021;323:30-36.
    PubMed     Abstract available
    
    
    March 2021
63. ZHANG JF, Meng X, Jing J, Pan Y, et al
    Serum calcium and long-term outcome after ischemic stroke: Results from the China National stroke registry III.
    Atherosclerosis. 2021;325:24-29.
    PubMed     Abstract available
    
    
    
64. SHI F, Sun L, Kaptoge S
    Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis.
    Atherosclerosis. 2021;320:70-78.
    PubMed     Abstract available
    
    
    February 2021
65. KISANUKI K, Muraki I, Yamagishi K, Kokubo Y, et al
    Weight change during middle age and risk of stroke and coronary heart disease: The Japan Public Health Center-based Prospective Study.
    Atherosclerosis. 2021;322:67-73.
    PubMed     Abstract available
    
    
    
66. XU M, Chen R, Liu L, Liu X, et al
    Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: The Dongfeng-Tongji cohort study.
    Atherosclerosis. 2021;323:20-29.
    PubMed     Abstract available
    
    
    
67. KEDHI E, Verdoia M, Suryapranata H, Damen S, et al
    Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.
    Atherosclerosis. 2021;321:39-44.
    PubMed     Abstract available
    
    
    January 2021
68. XIAO J, Padrick MM, Jiang T, Xia S, et al
    Acute ischemic stroke versus transient ischemic attack: Differential plaque morphological features in symptomatic intracranial atherosclerotic lesions.
    Atherosclerosis. 2021;319:72-78.
    PubMed     Abstract available
    
    
    
69. MANTELLA LE, Liblik K, Johri AM
    Vascular imaging of atherosclerosis: Strengths and weaknesses.
    Atherosclerosis. 2021;319:42-50.
    PubMed     Abstract available
    
    
    
70. LI HQ, Wang X, Wang HF, Zhang W, et al
    Dose-response relationship between blood pressure and intracranial atherosclerotic stenosis.
    Atherosclerosis. 2021;317:36-40.
    PubMed     Abstract available
    
    
    
71. HUANG YC, Chang CC, Yeh CC, Lin CS, et al
    The protective effect of statins against pressure ulcers in stroke patients: A propensity-score matched study based on a real-world database.
    Atherosclerosis. 2021;317:22-28.
    PubMed     Abstract available
    
    
    December 2020
72. ZDANYTE M, Wrazidlo RW, Kaltenbach S, Groga-Bada P, et al
    Predicting 1-, 3- and 5-year outcomes in patients with coronary artery disease: A comparison of available risk assessment scores.
    Atherosclerosis. 2020;318:1-7.
    PubMed     Abstract available
    
    
    November 2020
73. PENSON PE, Banach M
    Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes.
    Atherosclerosis. 2020;316:58-65.
    PubMed     Abstract available
    
    
    
74. KAUW F, de Jong PA, Takx RAP, de Jong HWAM, et al
    Effect of intravenous thrombolysis in stroke depends on pattern of intracranial internal carotid artery calcification.
    Atherosclerosis. 2020;316:8-14.
    PubMed     Abstract available
    
    
    
75. KEDHI E, Delewi R, Fabris E, De Luca G, et al
    Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials.
    Atherosclerosis. 2020;315:55-61.
    PubMed     Abstract available
    
    
    October 2020
76. BELL S, Gibson JT, Harshfield EL, Markus HS, et al
    Is periodontitis a risk factor for ischaemic stroke, coronary artery disease and subclinical atherosclerosis? A Mendelian randomization study.
    Atherosclerosis. 2020;313:111-117.
    PubMed     Abstract available
    
    
    September 2020
77. RENU A, Blasco J, Laredo C, Llull L, et al
    Carotid stent occlusion after emergent stenting in acute ischemic stroke: Incidence, predictors and clinical relevance.
    Atherosclerosis. 2020;313:8-13.
    PubMed     Abstract available
    
    
    
78. LIU X, Wu S, Song Q, Wang X, et al
    Visit-to-visit variability of lipid measurements and the risk of myocardial infarction and all-cause mortality: A prospective cohort study.
    Atherosclerosis. 2020 Sep 9. pii: S0021-9150(20)30493.
    PubMed     Abstract available
    
    
    March 2020
79. YAO Y, Zhu H, Zhu L, Fang Z, et al
    A comprehensive contribution of genetic variations of the insulin-like growth factor 1 signalling pathway to stroke susceptibility.
    Atherosclerosis. 2020;296:59-65.
    PubMed     Abstract available
    
    
    
80. MAZIDI M, Katsiki N, Mikhailidis DP, Banach M, et al
    Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies.
    Atherosclerosis. 2020;296:49-58.
    PubMed     Abstract available
    
    
    
81. ADINOLFI LE, Petta S, Fracanzani AL, Coppola C, et al
    Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study.
    Atherosclerosis. 2020;296:40-47.
    PubMed     Abstract available
    
    
    
82. SIMONETTO C, Heier M, Rospleszcz S, Meisinger C, et al
    Risk for cardiovascular events responds nonlinearly to carotid intima-media thickness in the KORA F4 study.
    Atherosclerosis. 2020;296:32-39.
    PubMed     Abstract available
    
    
    
83. WANG A, Dai L, Zhang N, Lin J, et al
    Oxidized low-density lipoprotein (LDL) and LDL cholesterol are associated with outcomes of minor stroke and TIA.
    Atherosclerosis. 2020;297:74-80.
    PubMed     Abstract available
    
    
    
84. LIM SS, Yang YL, Chen SC, Wu CH, et al
    Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
    Atherosclerosis. 2020;297:40-46.
    PubMed     Abstract available
    
    
    
85. THEN C, Then HL, Lechner A, Thorand B, et al
    Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study.
    Atherosclerosis. 2020;297:1-7.
    PubMed     Abstract available
    
    
    February 2020
86. HSIEH CY, Lee CH, Sung SF
    Development of a novel score to predict newly diagnosed atrial fibrillation after ischemic stroke: The CHASE-LESS score.
    Atherosclerosis. 2020;295:1-7.
    PubMed     Abstract available
    
    
    January 2020
87. CHARACH G, Karniel E, Novikov I, Galin L, et al
    Reduced bile acid excretion is an independent risk factor for stroke and mortality: A prospective follow-up study.
    Atherosclerosis. 2020;293:79-85.
    PubMed     Abstract available
    
    
    
88. MUNOZ-TORRERO JFS, Zamorano J, Rico-Martin S, Rivas MD, et al
    Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease.
    Atherosclerosis. 2020;292:84-89.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge.